Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  7. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  8. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  9. Song R, et al. 2022. Immunology. 165:274. PubMed
  10. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  11. He D, et al. 2022. Immunity. 55:159. PubMed
  12. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  13. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  14. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  15. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  16. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  17. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  18. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  19. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  20. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  21. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  22. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  23. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  24. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  25. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  26. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  27. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  28. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  29. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  30. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  31. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  32. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  33. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  34. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  35. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  36. Chan L, et al. 2022. Cells. 12: . PubMed
  37. Wang L, et al. 2022. Nutrients. 15: . PubMed
  38. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  39. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  40. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  41. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  42. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  43. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  44. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  45. Schick J, et al. 2023. Elife. 12: . PubMed
  46. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  47. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  48. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  49. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  50. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  51. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  52. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  53. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  54. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  55. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  56. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  57. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  58. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  59. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  60. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  61. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  62. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  63. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  64. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  65. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  66. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  67. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  68. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  69. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  70. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  71. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  72. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  73. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  74. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  75. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  76. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  77. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  78. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  79. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  80. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  81. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  82. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  83. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  84. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  85. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  86. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  87. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  88. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  89. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  90. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  91. Qin C, et al. 2023. iScience. 26:106588. PubMed
  92. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  93. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  94. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  95. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  96. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  97. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  98. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  99. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  100. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  101. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  102. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  103. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  104. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  105. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  106. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  107. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  108. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  109. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  110. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  111. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  112. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  113. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  114. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  115. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  116. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  117. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  118. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  119. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  120. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  121. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  122. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  123. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  124. Poli V, et al. 2021. iScience. 24:103256. PubMed
  125. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  126. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  127. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  128. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  129. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  130. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  131. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  132. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  133. Chen S, et al. 2022. Cancer Discov. :. PubMed
  134. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  135. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  136. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  137. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  138. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  139. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  140. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  141. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  142. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  143. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  144. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  145. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  146. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  147. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  148. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  149. Li B, et al. 2022. iScience. 25:103772. PubMed
  150. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  151. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  152. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  153. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  154. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  155. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  156. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  157. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  158. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  159. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  160. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  161. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  162. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  163. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  164. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  165. Kasper M, et al. 2021. Elife. 10:. PubMed
  166. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  167. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  168. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  169. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  170. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  171. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  172. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  173. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  174. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  175. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  176. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  177. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  178. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  179. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  180. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  181. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  182. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  183. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  184. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  185. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  186. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  187. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  188. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  189. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  190. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  191. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  192. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  193. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  194. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  195. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  196. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  197. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  198. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  199. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  200. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  201. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  202. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  203. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  204. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  205. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  206. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  207. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  208. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  209. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  210. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  211. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  212. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  213. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  214. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  215. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  216. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  217. Gao H, et al. 2021. Cells. 10:. PubMed
  218. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  219. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  220. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  221. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  222. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  223. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  224. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  225. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  226. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  227. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  228. Köchl R, et al. 2020. Elife. 9:00. PubMed
  229. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  230. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  231. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  232. Dong S, et al. 2021. Nature. 591:117. PubMed
  233. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  234. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  235. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  236. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  237. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  238. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  239. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  240. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  241. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  242. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  243. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  244. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  245. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  246. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  247. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  248. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  249. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  250. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  251. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  252. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  253. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  254. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  255. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  256. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  257. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  258. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  259. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  260. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  261. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  262. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  263. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  264. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  265. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  266. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  267. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  268. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  269. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  270. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  271. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  272. Cho K, et al. 2021. iScience. 24:103117. PubMed
  273. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  274. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  275. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  276. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  277. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  278. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  279. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  280. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  281. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  282. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  283. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  284. Dong L, et al. 2022. Cells. 11:. PubMed
  285. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  286. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  287. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  288. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  289. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  290. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  291. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  292. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  293. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  294. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  295. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  296. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  297. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  298. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  299. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  300. Liu P, et al. 2022. iScience. 25:103867. PubMed
  301. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  302. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  303. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  304. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  305. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  306. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  307. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  308. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  309. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  310. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  311. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  312. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  313. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  314. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  315. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  316. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  317. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  318. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  319. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  320. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  321. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  322. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  323. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  324. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  325. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  326. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  327. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  328. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  329. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  330. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  331. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  332. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  333. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  334. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  335. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  336. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  337. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  338. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  339. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  340. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  341. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  342. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  343. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  344. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  345. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  346. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  347. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  348. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  349. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  350. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  351. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  352. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  353. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  354. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  355. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  356. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  357. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  358. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  359. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  360. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  361. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  362. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  363. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  364. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  365. Tang S, et al. 2022. Virol J. 19:32. PubMed
  366. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  367. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  368. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  369. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  370. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  371. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  372. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  373. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  374. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  375. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  376. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  377. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  378. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  379. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  380. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  381. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  382. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  383. Wang X, et al. 2022. Elife. 11:. PubMed
  384. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  385. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  386. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  387. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  388. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  389. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  390. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  391. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  392. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  393. Liu SS, et al. 2021. Immunity. :. PubMed
  394. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  395. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  396. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  397. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  398. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  399. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  400. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  401. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  402. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  403. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  404. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  405. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  406. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  407. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  408. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  409. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  410. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  411. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  412. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  413. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  414. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  415. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  416. Wang S, et al. 2022. Blood. 140:171. PubMed
  417. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  418. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  419. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  420. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  421. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  422. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  423. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  424. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  425. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  426. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  427. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  428. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  429. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312788 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD11b on UniProt.org

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account